These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24731538)

  • 1. Development of the Addiction Dimensions for Assessment and Personalised Treatment (ADAPT).
    Marsden J; Eastwood B; Ali R; Burkinshaw P; Chohan G; Copello A; Burn D; Kelleher M; Mitcheson L; Taylor S; Wilson N; Whiteley C; Day E
    Drug Alcohol Depend; 2014 Jun; 139():121-31. PubMed ID: 24731538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the reliability and validity of the Addiction Severity Index.
    Mäkelä K
    Addiction; 2004 Apr; 99(4):398-410; discussion 411-8. PubMed ID: 15049734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of substance use and psychiatric disorders in a highly select chronic pain population.
    Proctor SL; Estroff TW; Empting LD; Shearer-Williams S; Hoffmann NG
    J Addict Med; 2013; 7(1):17-24. PubMed ID: 23131838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of DSM-IV Axis V scales in a clinical sample of veterans with posttraumatic stress disorder.
    Jovanović AA; Gasić MJ; Ivković M; Milovanović S; Damjanović A
    Psychiatr Danub; 2008 Sep; 20(3):286-300. PubMed ID: 18827754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S; Aubry JM; Gex-Fabry M; Ragama-Pardos E; McQuillan A; Bertschy G
    Encephale; 2003; 29(6):499-505. PubMed ID: 15029084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and initial evaluation of the Brief Addiction Monitor (BAM).
    Cacciola JS; Alterman AI; Dephilippis D; Drapkin ML; Valadez C; Fala NC; Oslin D; McKay JR
    J Subst Abuse Treat; 2013 Mar; 44(3):256-63. PubMed ID: 22898042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of the Japanese version of the Addiction Severity Index (ASI-J).
    Senoo E; Ogai Y; Haraguchi A; Kondo A; Ishibashi Y; Umeno M; Kikumoto H; Hori T; Komiyama T; Kato R; Aso K; Asukai N; Wada K; Saitoh S; Ikeda K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):368-79. PubMed ID: 17037345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychometric analysis of the dimension rating system--2nd edition.
    May WW
    J Addict Dis; 2004; 23(4):85-112. PubMed ID: 15339716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the Hungarian version of the European Addiction Severity Index.
    Gerevich J; Bácskai E; Kó J; Rózsa S
    Psychopathology; 2005; 38(6):301-9. PubMed ID: 16224203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development, validity, and reliability of the Addiction Profile Index (API).
    Ögel K; Evren C; Karadağ F; Gürol DT
    Turk Psikiyatri Derg; 2012; 23(4):263-75. PubMed ID: 23225127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addiction severity assessment tool: development of a self-report measure for clients in substance abuse treatment.
    Butler SF; Budman SH; McGee MD; Davis MS; Cornelli R; Morey LC
    Drug Alcohol Depend; 2005 Dec; 80(3):349-60. PubMed ID: 15994028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergent validity of the ASAM criteria in co-occurring disorders.
    Stallvik M; Nordahl HM
    J Dual Diagn; 2014; 10(2):68-78. PubMed ID: 25392248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The symptom and function dimensions of the Global Assessment of Functioning (GAF) scale.
    Pedersen G; Karterud S
    Compr Psychiatry; 2012 Apr; 53(3):292-8. PubMed ID: 21632038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of item response theory to quantify substance use disorder severity.
    Kirisci L; Tarter RE; Vanyukov M; Martin C; Mezzich A; Brown S
    Addict Behav; 2006 Jun; 31(6):1035-49. PubMed ID: 16647219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users.
    Fridell M; Hesse M
    Addict Behav; 2006 Apr; 31(4):559-65. PubMed ID: 15967584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical assessment in drug addicts: reliability and validity of the Cumulative Illness Rating Scale (Substance Abuse version).
    Castillo C; Bulbena A; Serras E; Torrens M; López-Colomés JL; Martínez MA; Politinska B
    Eur Addict Res; 2004; 10(3):112-7. PubMed ID: 15258441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
    Wu LT; Ling W; Burchett B; Blazer DG; Yang C; Pan JJ; Reeve BB; Woody GE
    Drug Alcohol Depend; 2011 Nov; 118(2-3):186-93. PubMed ID: 21501933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the French version of the arthritis impact measurement scales 2 and comparison with the french version of the Nottingham Health Profile. "Quality of Life in Rheumatology" Task Force.
    Pouchot J; Guillemin F; Coste J; Brégeon C; Sany J
    Rev Rhum Engl Ed; 1996 Jun; 63(6):389-404. PubMed ID: 8817749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and research utility of Spanish Teen-Addiction Severity Index (T-ASI).
    Díaz R; Castro-Fornieles J; Serrano L; González L; Calvo R; Goti J; Kaminer Y; Gual A
    Addict Behav; 2008 Jan; 33(1):188-95. PubMed ID: 17601676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.